Literature DB >> 9311604

Radiation-induced apoptosis in human ovarian carcinoma cells growing as a monolayer and as multicell spheroids.

I V Filippovich1, N I Sorokina, N Robillard, J F Chatal.   

Abstract

Response to external gamma irradiation was studied in a human ovarian carcinoma cell line (OVCAR 3) growing as a monolayer and as multicell spheroids. Necrosis and apoptosis were documented using Trypan-blue uptake and acridine-orange staining, respectively, and apoptosis was quantified using a terminal deoxynucleotidyl transferase assay. Exposure of OVCAR 3 cells growing as a monolayer to 137Cs gamma radiation at a dose of 10 Gy produced 30-40% apoptosis 72 hr after irradiation. Cell-cycle analysis of irradiated cells showed an accumulation of cells in G2/M phase 24 hr after irradiation and then a decline at 48 hr in conjunction with apoptosis onset. The loss of G0/G1 cells in irradiated cultures suggested a preferential entry into apoptosis. No increase in apoptotic cell number was observed in OVCAR 3 spheroids after irradiation, and the cells probably died as a result of necrosis. When spheroids were disrupted immediately after irradiation to obtain a cell suspension, minor apoptosis was observed in association with a marked increase in TB-positive cell number after 96 hr of incubation following irradiation. Thus, a relationship was found between radiation-induced apoptosis and the cell cycle. Results with spheroids suggested the possible involvement of cell-to-cell interactions in apoptosis regulation.

Entities:  

Mesh:

Year:  1997        PMID: 9311604     DOI: 10.1002/(sici)1097-0215(19970904)72:5<851::aid-ijc23>3.0.co;2-a

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Detection of high molecular weight DNA fragments characteristic of early stage apoptosis in cerebellar granule cells exposed to glutamate.

Authors:  H H Slagsvold; O J Marvik; G Eidem; N Kristoffersen; R E Paulsen
Journal:  Exp Brain Res       Date:  2000-11       Impact factor: 1.972

2.  Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.

Authors:  R C Casey; K M Burleson; K M Skubitz; S E Pambuccian; T R Oegema; L E Ruff; A P Skubitz
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Effect of exogenous wild-type p53 on melanoma cell death pathways induced by irradiation at different linear energy transfer.

Authors:  Feng-Ling Min; Hong Zhang; Wen-Jian Li; Qing-Xiang Gao; Guang-Ming Zhou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Sep-Oct       Impact factor: 2.416

4.  Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.

Authors:  Kathryn M Burleson; Linda K Hansen; Amy P N Skubitz
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.

Authors:  Fardous F El-Senduny; Farid A Badria; Ahmed M El-Waseef; Subhash C Chauhan; Fathi Halaweish
Journal:  Tumour Biol       Date:  2015-08-05

6.  Models of ovarian cancer metastasis: Murine models.

Authors:  Sanja Sale; Sandra Orsulic
Journal:  Drug Discov Today Dis Models       Date:  2006-06-01

7.  Disaggregation and invasion of ovarian carcinoma ascites spheroids.

Authors:  Kathryn M Burleson; Matthew P Boente; Stefan E Pambuccian; Amy P N Skubitz
Journal:  J Transl Med       Date:  2006-01-24       Impact factor: 5.531

8.  Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.

Authors:  Mark Desjardins; Jia Xie; Hilal Gurler; Goda G Muralidhar; Joelle D Sacks; Joanna E Burdette; Maria V Barbolina
Journal:  J Ovarian Res       Date:  2014-06-26       Impact factor: 4.234

9.  Targeted alpha therapy approach to the management of pancreatic cancer.

Authors:  Barry J Allen; Syed M Abbas Rizvi; Chang F Qu; Ross C Smith
Journal:  Cancers (Basel)       Date:  2011-04-01       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.